Released Nov 2, 2012, during market hours
10-Q filed Nov 2, 2012, 33 days after period end · 0001193125-12-448885
Q3 2012 · 10-Q
Revenue$105.82M$105.82M −5.1% vs Q3 2011−5.2% vs Q2 2012
Net Income$3.75M$3.75M −62.8% vs Q3 2011−57.4% vs Q2 2012
EPS Diluted$0.19$0.19 −64.8% vs Q3 2011−58.7% vs Q2 2012
Gross Profit$80,931,000−8.4%
Operating Income$16,943,000−19.2%
Operating Cash Flowderived$10,638,000−34.3%
Free Cash Flowderived$5,220,000−49.5%
Margins · derived
Gross margin76.5%−2.8 pt vs Q3 2011
Operating margin16.0%−2.8 pt vs Q3 2011
Net margin3.5%−5.5 pt vs Q3 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $105.82M | $111.51M | $138.91M |
| Net Income | $3.75M | $10.08M | $8.52M |
| EPS Diluted | $0.19 | $0.54 | $0.48 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR